Aktis Oncology, Inc. Common stock AKTS

$16.55 -0.45% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-11-12 View →
8-K 8-K 2026-11-12 View →
4 4 2026-09-24 View →
10-Q 10-Q 2026-08-13 View →
8-K 8-K 2026-08-13 View →
4 4 2026-07-21 View →
4 4 2026-07-20 View →
4 4 2026-07-10 View →
4 4 2026-07-10 View →
10-Q 10-Q 2026-05-11 View →
8-K 8-K 2026-05-11 View →
4 4 2026-04-16 View →
8-K 8-K 2026-04-16 View →
8-K 8-K 2026-03-30 View →
10-K 10-K 2026-03-30 View →
4 Insider transaction 2026-01-14 View →
4 Insider transaction 2026-01-14 View →
4 Insider transaction 2026-01-14 View →
4 Insider transaction 2026-01-12 View →
4 4 2026-01-12 View →
4 4 2026-01-12 View →
4 4 2026-01-12 View →
8-K 8-K 2026-01-12 View →
S-1 S-1 2025-12-19 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$16.55
Market Cap
$927.36 million
52-Week Range
$13.96 – $34.19
Average Volume
359K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.